SURMATRIX
Live / Allowed — Publication / registration review complete (as of 17 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 07 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99124349
- Mark type
- Stylized text
- Filed
- 07 Apr 2025
- Published for opposition
- 07 Apr 2026
- Attorney of record
- Paul C. Llewellyn
Goods and services
- Class 005 — Pharmaceuticals: Amniotic liquid human allograft tissue; Liquid biological preparations derived from human amnion, amniotic fluid and umbilical cord for the treatment of wounds, ulcers, burns, scars, surgical incisions, joint pain, osteoarthritis, tendinopathy, soft tissue repair, sports injuries, Mohs surgery scarring, and post-operative pain; Processed human donor skin for the replacement of soft tissue; injectable flowable human amniotic membrane allograft tissue; Flowable human allograft tissue derived from donated human amniotic membrane; Bone void fillers consisting of biological materials, namely, bone graft putty derived from demineralized bone matrix (DBM) for medical purposes; Implantable living tissue, namely, bone, demineralized bone matrix, and derivatives of demineralized bone powder; Bone grafting products, namely, bone implants comprised of living tissue; Bone regenerating products comprised of living tissue, namely, demineralized bone matrix and derivatives of demineralized bone powder; Human allograft bone and tissue; Human allograft tissue in the nature of demineralized bone matrix used for use in surgical procedures; Surgical implants for the bone comprising living tissue in the nature of demineralized bone matrix for use in surgical procedures; Biological demineralized bone matrix human allograft tissue intended for subsequent implantation
Owner
- Surgenex Holdings, LLC, Scottsdale, AZ, US
Prosecution history
- 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 12 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 12 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 12 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
- 06 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Mar 2026 — NON-FINAL ACTION E-MAILED
- 06 Mar 2026 — NON-FINAL ACTION WRITTEN
- 05 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Dec 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 08 Dec 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 04 Nov 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS